SCHEMBL5078804

SCHEMBL5078804

CCCn1cnc2c(=O)[nH]c(=O)n(-c3ccc(Cl)cc3)c21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.44
CNR1 P21554 1/20 0.43
PDE4A P27815 4/20 0.42
PDE4B Q07343 4/20 0.42
PDE4C Q08493 4/20 0.42
PDE4D Q08499 4/20 0.42
ADORA2A P29274 3/20 0.42
BRD4 O60885 1/20 0.42
BRD2 P25440 1/20 0.42
BRD3 Q15059 1/20 0.42
BRDT Q58F21 1/20 0.42
TSHR P16473 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
XDH P47989 1/20 0.40
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7421519 0.82 PNP (0.49) CNR1PDE4ABRD4BRD2BRD3
SCHEMBL7604062 0.73 PNP (0.53) PDE4ABRD4SMN1; SMN2MEN1KMT2A
SCHEMBL6251096 0.73 PDE4A (0.64) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL3990425 0.71 PDE4A (0.57) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL4623458 0.71 PDE4A (0.63) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL7421933 0.71 PNP (0.47) PDE4APDE4BPDE4CPDE4DBRD4
SCHEMBL27483073 0.70 KMT2A (0.48) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL13111704 0.69 NPC1 (0.56) NPC1CNR1PDE4APDE4BPDE4C
SCHEMBL5438914 0.68 TSHR (0.49) NPC1CNR1PDE4APDE4BPDE4C
SCHEMBL8648439 0.68 BRD4 (0.44) BRD4BRD2BRD3BRDTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1956906-A2 METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF MEDICAL CONDITIONS CombinatoRx, Incorporated (US) 2008-08-20 EP disclosed
WO-2007056457-A2 METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF MEDICAL CONDITIONS COMBINATORX, INCORPORATED (US) 2007-05-18 WO disclosed
EP-1562602-A2 IMMEDIATE RELEASE TOPICAL PHARMACEUTICAL FORMULATION FOR ENHANCEMENT OF FEMALE SEXUAL DESIRE AND RESPONSIVENESS Vivus, Inc. (US) 2005-08-17 EP disclosed
WO-2004037262-A2 IMMEDIATE RELEASE TOPICAL PHARMACEUTICAL FORMULATION FOR ENHANCEMENT OF FEMALE SEXUAL DESIRE AND RESPONSIVENESS VIVUS, INC. (US) 2004-05-06 WO disclosed